TML-6 is an orally available curcumin derivative that inhibits synthesis of beta-amyloid (Abeta) and Abeta precursor protein, upregulates Apo E, activates Nrf2, suppresses NF-kappaB and mTOR, and ameliorates inflammation. It is suitable for Alzheimers disease research.
Molecular Weight:
523.62
Purity:
99.71%
CAS Number:
[1462868-88-7]
Formula:
C30H37NO7
Target:
Nrf2|||mTOR|||NF-kappaB|||Beta Amyloid|||Others
T37148
* VAT and and shipping costs not included. Errors and price changes excepted
